Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
As Democrats get set to take control of both chambers of Congress, medtech looks for reauthorization of FDA user fees and more. The power shift in Washington, DC is significant, but its impact on medtech is unpredictable.
Singapore possesses many of the capabilities needed to build successful medtech companies. MedTech Catapult, a national platform hosted by the Agency for Science, Technology and Research (A*STAR), Singapore’s lead public sector R&D agency, aims to connect and build upon these strengths to accelerate promising innovations toward commercial success, and, in the process, to further strengthen Singapore’s medtech ecosystem.
Medtech companies, weighed down by depressed stock prices and market challenges, are under intense pressure to step out of their comfort zones and make bets on innovation that will drive their future. Excerpted from our recent feature article, Despite Headwinds, A Nascent Medtech Rebound Is Fueling M&A.